BioMed Research International / 2019 / Article / Tab 1 / Review Article
Heterotopic Ossification: A Challenging Complication of Total Hip Arthroplasty: Risk Factors, Diagnosis, Prophylaxis, and Treatment Table 1 Summary of the most relevant finding in literature.
Author Year Results Schmidt et al. [15 ] 1988 Indomethacin is especially recommended for patients who are at high risk for HO. Wright et al. [16 ] 1994 The severity of HO did not correlate with the HHS; the relationship between HO and range of motion (ROM) indicates that the Brooker index is a valid measurement. Fingeroth et al. [17 ] 1995 A single dose of 6 Gy of radiation given within the first 3 postoperative days provides effective prophylaxis against HO. Seegenschmiedt et al. [18 ] 2001 Both preoperative (within 24 h) and postoperative RT (within 72 h) are effective in preventing HO after hip surgery. Saudan et al. [13 ] 2007 Celecoxib was more effective than ibuprofen in preventing heterotopic bone formation after total hip replacement. Xu et al. [11 ] 2014 Considering the side effects of nonselective NSAIDs, selective COX-2 inhibitors were recommend for the prevention of HO after THA. Lavernia et al. [9 ] 2014 A short course of celecoxib for pain aids in the prevention of HO after primary THR. Winkler et al. [8 ] 2016 Etoricoxib and diclofenac are equally effective for oral HO prophylaxis after primary cementless THA when given for nine peri-operative days.